These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9237135)

  • 21. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 22. Medicare may not reimburse for certain AIDS and cancer drugs.
    Baker R
    BETA; 1995 Sep; ():11-2. PubMed ID: 11362882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
    Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Spector SA
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):9-12, 15-22. PubMed ID: 11363539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant.
    Tawse KL; Baumal CR
    J AAPOS; 2014 Feb; 18(1):78-80. PubMed ID: 24568990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
    Chou S; Miner RC; Drew WL
    J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.
    Arevalo JF; Gonzalez C; Capparelli EV; Kirsch LS; Garcia RF; Quiceno JI; Connor JD; Gambertoglio J; Bergeron-Lynn G; Freeman WR
    J Infect Dis; 1995 Oct; 172(4):951-6. PubMed ID: 7561215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 31. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
    Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
    N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganciclovir resistance: a matter of time and titre.
    Drew WL
    Lancet; 2000 Aug; 356(9230):609-10. PubMed ID: 10968428
    [No Abstract]   [Full Text] [Related]  

  • 33. Current management of cytomegalovirus infection: treatment and prophylaxis.
    Hardy D
    Am J Health Syst Pharm; 1996 Apr; 53(8 Suppl 2):S12-6; discussion S17. PubMed ID: 8728376
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA
    N Engl J Med; 1997 Jul; 337(2):105-14. PubMed ID: 9211681
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of clinically resistant cytomegalovirus retinitis in AIDS patients: combination of intravenous ganciclovir and intravitreal foscarnet.
    Pivetti-Pezzi P; Accorinti M; Ciapparoni V; Vullo V
    Eur J Ophthalmol; 1995; 5(4):199-203. PubMed ID: 8963154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
    Jacobson MA
    Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic options for resistant cytomegalovirus retinitis.
    Kuppermann BD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
    Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
    Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Present status and advances in pharmacotherapy for cytomegalovirus retinitis associated with acquired immunodeficiency syndrome].
    Wang WW; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1148-52. PubMed ID: 21211231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.